Dr Subhash Vasudevan is Associate Professor and Principal Investigator in the Program for Emerging Infectious Diseases at the Duke-NUS Graduate Medical School in Singapore.  He is also an Editor of Antiviral Research (Elsevier).  Dr Vasudevan obtained his Ph.D. from The Australian National University and postdoctoral training at the Max Planck Institute for Biophysics. Previously he was a Reader in Biochemistry and Molecular Biology at James Cook University in Australia and also Head of the Dengue Research Unit at Novartis Institute of Tropical Diseases. His major research interest is in the field of molecular virology and antiviral therapeutics.